Clinical Trials on Hyperphagia in Hong Kong

Total 29 results

Chinese University of Hong Kong

Completed

Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

Benign Prostate Hyperplasia

Hong Kong
Chinese University of Hong Kong

Terminated

Waterjet Prostate Ablation

Benign Prostatic Hyperplasia

Hong Kong
Chinese University of Hong Kong
Koelis

Recruiting

BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY

Prostate Hyperplasia

Hong Kong
Chinese University of Hong Kong
School of Pharmacy, CUHK

Completed

Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia

Benign Prostate Hyperplasia

Hong Kong
Chinese University of Hong Kong

Terminated

The Use of REZUM System in Chinese Male Patients With LUTS Secondary to Benign Prostate Enlargement

Benign Prostatic Hyperplasia

Hong Kong
The University of Hong Kong

Unknown

Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men

Prostatic Hyperplasia | Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong

Benign Prostatic Hyperplasia

Hong Kong
Hospital Authority, Hong Kong

Unknown

The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients

Prostatic Hyperplasia | Adrenergic Alpha-Antagonists

China
Chinese University of Hong Kong

Recruiting

Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH

Prostate Hyperplasia

Hong Kong
Hospital Authority, Hong Kong

Terminated

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Prostatic Hyperplasia | Urinary Retention

China
Chinese University of Hong Kong

Active, not recruiting

To Linguistically and Psychometrically Validate the Hong Kong Chinese Version of the BPH 3-item Questionnaire

Benign Prostatic Hyperplasia (BPH)

Hong Kong
Hospital Authority, Hong Kong

Completed

Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS

Prostatic Hyperplasia | Impotence

China
Hospital Authority, Hong Kong

Terminated

Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Prostatic Hyperplasia | Acute Disease | Urinary Retention

China
The University of Hong Kong

Unknown

Diode Laser in Gingival Enlargement Related to Orthodontics

Gingival Overgrowth

China
PROCEPT BioRobotics

Recruiting

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Benign Prostatic Hyperplasia | Localized Prostate Cancer

Lebanon, Hong Kong, United States
University of California, Irvine
Pomegranate Health; Jarrow Pharmaceuticals

Unknown

Study of the Effects of Pomegranate Tablets on Enlarged Prostates

Benign Prostatic Hyperplasia

United States
Merit Medical Systems, Inc.

Terminated

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Medi-Tate Ltd.

Completed

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device

Benign Prostate Hyperplasia

United States, Canada
GlaxoSmithKline

Completed

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

Prostatic Hyperplasia

United States
Merit Medical Systems, Inc.

Completed

Embosphere® PROstate Post Market Study (PROstate)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States, United Kingdom, Italy, France
Sophiris Bio Corp

Completed

Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
PROCEPT BioRobotics

Completed

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II (WATERII)

Benign Prostatic Hyperplasia (BPH)

United States, Canada
Nymox Corporation

Completed

Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)

Benign Prostatic Hyperplasia (BPH) | Enlarged Prostate

United States
Threshold Pharmaceuticals

Terminated

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Nymox Corporation

Completed

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Watson Pharmaceuticals

Completed

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Benign Prostatic Hyperplasia (BPH)

United States
Eli Lilly and Company

Completed

A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms

Benign Prostatic Hyperplasia | Enlarged Prostate

United States, Italy, France, Belgium, Mexico, Argentina, Greece, Germany, Canada, Russian Federation, Poland, Turkey, Brazil
Watson Pharmaceuticals

Completed

The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months

Benign Prostatic Hyperplasia

United States
Sophiris Bio Corp

Completed

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH (PLUS-1)

Benign Prostatic Hyperplasia

United States, Australia, Canada, Russian Federation, Ukraine, New Zealand

Clinical Trials on Hyperphagia in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations